Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

New antiepileptic drugs: lacosamide, rufinamide, and vigabatrin.

Strom LA, Koh S, Frey L.

Curr Treat Options Neurol. 2010 Jul;12(4):287-99. doi: 10.1007/s11940-010-0079-4.

PMID:
20842588
2.

Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.

Wisniewski CS.

Ann Pharmacother. 2010 Apr;44(4):658-67. doi: 10.1345/aph.1M679. Epub 2010 Mar 16. Review.

PMID:
20233912
3.

Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.

Wier HA, Cerna A, So TY.

Paediatr Drugs. 2011 Apr 1;13(2):97-106. doi: 10.2165/11586920-000000000-00000. Review.

PMID:
21351809
4.

Rufinamide for the treatment of Lennox-Gastaut syndrome.

Besag FM.

Expert Opin Pharmacother. 2011 Apr;12(5):801-6. doi: 10.1517/14656566.2011.560836. Epub 2011 Feb 24. Review.

PMID:
21348771
5.

Rufinamide: a new antiepileptic drug treatment for Lennox-Gastaut syndrome.

Ferrie CD.

Expert Rev Neurother. 2010 Jun;10(6):851-60. doi: 10.1586/ern.10.51. Review.

PMID:
20518600
6.

Management of seizures in Lennox-Gastaut syndrome.

Crumrine PK.

Paediatr Drugs. 2011 Apr 1;13(2):107-18. doi: 10.2165/11536940-000000000-00000. Review.

PMID:
21351810
7.

Rufinamide.

Arroyo S.

Neurotherapeutics. 2007 Jan;4(1):155-62. Review.

PMID:
17199032
8.

The spectrum of the new antiepileptic drugs.

Perucca E.

Acta Neurol Belg. 1999 Dec;99(4):231-8. Review.

PMID:
10674140
9.

Place of newer antiepileptic drugs in the treatment of epilepsy.

Kälviäinen R, Keränen T, Riekkinen PJ Sr.

Drugs. 1993 Dec;46(6):1009-24. Review.

PMID:
7510609
10.

Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.

Coppola G, Besag F, Cusmai R, Dulac O, Kluger G, Moavero R, Nabbout R, Nikanorova M, Pisani F, Verrotti A, von Stülpnagel C, Curatolo P.

Eur J Paediatr Neurol. 2014 Nov;18(6):685-90. doi: 10.1016/j.ejpn.2014.05.008. Epub 2014 May 28. Review.

PMID:
24929673
11.

Pharmacological management of epilepsy: recent advances and future prospects.

Johannessen Landmark C, Johannessen SI.

Drugs. 2008;68(14):1925-39. Review.

PMID:
18778117
12.

Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.

Alvarez N, Besag F, Iivanainen M.

J Intellect Disabil Res. 1998 Dec;42 Suppl 1:1-15. Review.

PMID:
10030426
13.

Lacosamide in patients with pharmacoresistant epilepsy.

Verrotti A, Loiacono G, Olivieri C, Zulli E, Zaccara G.

Expert Opin Pharmacother. 2012 Oct;13(14):2065-72. doi: 10.1517/14656566.2012.713347. Epub 2012 Aug 8. Review.

PMID:
22873760
14.

The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.

Connock M, Frew E, Evans BW, Bryan S, Cummins C, Fry-Smith A, Li Wan Po A, Sandercock J.

Health Technol Assess. 2006 Mar;10(7):iii, ix-118. Review.

15.

Rufinamide.

Deeks ED, Scott LJ.

CNS Drugs. 2006;20(9):751-60; discussion 761. Review.

PMID:
16953653
16.

[New antiepileptic drugs in childhood epilepsies: indications and limits].

Kaminska A.

Epileptic Disord. 2001;3 Spec No 2:SI37-46. Review. French.

17.

[Therapeutic options provided by new antiepileptic drugs].

Baulac M, Arzimanoglou A, Semah F, Cavalcanti D.

Rev Neurol (Paris). 1997 Feb;153(1):21-33. Review. French.

PMID:
9296153
18.

Pharmacology and therapeutic aspects of antiepileptic drugs in pediatrics.

Dodson WE, Bourgeois BF.

J Child Neurol. 1994 Oct;9 Suppl 2:1-7. Review.

PMID:
7806779
19.

Seizure-inducing effects of antiepileptic drugs: a review.

Bauer J.

Acta Neurol Scand. 1996 Dec;94(6):367-77. Review.

PMID:
9017023
20.

Treatment of pediatric epilepsy: European expert opinion, 2007.

Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D.

Epileptic Disord. 2007 Dec;9(4):353-412. Review.

Supplemental Content

Support Center